U-NWBO

Q:NWBO - NORTHWEST BIOTHERAPEUTICS INC - https://www.nwbio.com/

11:30:50 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
NWBO - Q	not subscribed					0.2539	-0.00085	-0.3	842.6	205	237	0.2569 0.2569 0.25	0.4788 0.1684	11:12:26	Jun 11	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
OTC Markets Indicators -- Primary Market: OTC Markets -- Tier: OTCQB -- Status: Active

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Portfolio

Recent Trades - Last 10 of 237

More trades...

Time ET	Ex	Price	Change	Volume
11:12:26	Q	0.2539	-0.00085	4,105
11:12:25	Q	0.2512	-0.00355	495
11:11:06	Q	0.2516	-0.00315	10,300
11:11:06	Q	0.251	-0.00375	797
11:11:06	Q	0.25	-0.00475	140
11:11:06	Q	0.25	-0.00475	100
11:09:34	Q	0.2516	-0.00315	385
11:09:05	Q	0.2501	-0.00465	150
11:09:05	Q	0.254	-0.00075	150
11:05:59	Q	0.2512	-0.00355	1,961

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2025-06-11 12:49	U:NWBO	News Release200	Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments
2024-12-26 09:30	U:NWBO	News Release200	Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing

Date ET

Symbol

Type

Headline

2025-06-11 12:49

U:NWBO

News Release

Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments

2024-12-26 09:30

U:NWBO

News Release

Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing